2021
Hemophilia Gene Therapy Value Assessment: Methodological Challenges and Recommendations
Garrison L, Pezalla E, Towse A, Yang H, Faust E, Wu E, Li N, Sawyer E, Recht M. Hemophilia Gene Therapy Value Assessment: Methodological Challenges and Recommendations. Value In Health 2021, 24: 1628-1633. PMID: 34711363, DOI: 10.1016/j.jval.2021.05.008.Peer-Reviewed Original ResearchConceptsGene therapyDurability of benefitAbsence of randomized controlled trialsQuality of life measuresHemophilia gene therapyLong-term outcomesHealthcare system perspectiveShort-term therapySelf-controlled trialRandomized Controlled TrialsLong-term health benefitsLife measuresOne-time treatmentExpert clinical opinionLong-term benefitsTherapyHemophiliaConventional treatmentControlled TrialsChoice of perspectiveClinical opinionLead-InChronic diseasesTreatmentComparative effectiveness
2019
Electromagnetic Interference with Protocolized Electrosurgery Dispersive Electrode Positioning in Patients with Implantable Cardioverter Defibrillators.
Schulman PM, Treggiari MM, Yanez ND, Henrikson CA, Jessel PM, Dewland TA, Merkel MJ, Sera V, Harukuni I, Anderson RB, Kahl E, Bingham A, Alkayed N, Stecker EC. Electromagnetic Interference with Protocolized Electrosurgery Dispersive Electrode Positioning in Patients with Implantable Cardioverter Defibrillators. Anesthesiology 2019, 130: 530-540. PMID: 30601218, DOI: 10.1097/aln.0000000000002571.Peer-Reviewed Original ResearchConceptsImplantable cardioverter defibrillatorCardiac surgeryNoncardiac surgeryCardioverter defibrillatorAntitachycardia therapyMonopolar electrosurgeryElectrode positioningInappropriate antitachycardia therapyProspective cohort studyHeart Rhythm SocietyExpert clinical opinionAcademic medical centerPaucity of dataCohort studyCurrent management recommendationsProtocolized ApproachMedical CenterClinical opinionSurgeryPatientsUmbilicusTherapyDefibrillatorDispersive electrodeAmerican Society
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply